Boston Scientific delays Penumbra acquisition closing to Q1 2027

Boston Scientific updated the timeline for its $14.5 billion acquisition of Penumbra, now expected to close in Q1 2027 due to regulatory processes. The company said higher interest rates have increased financing costs, creating an earnings drag and reducing the deal's overall benefits.

Detected & updated continuously · Source: Nebula